Skip to main content
. Author manuscript; available in PMC: 2010 Oct 28.
Published in final edited form as: Hepatology. 1983 Jul–Aug;3(4):581–587. doi: 10.1002/hep.1840030418

Table 2.

Histopathologic Studies

Group Description n Hepatocyte size units
(mean ± S.D.)
pa No. of labeled
hepatocytes
per 100
hepatocytesb
(mean ± S.D.)
pa
Before 2 weeks Sacrifice Sacrifice
1 PCS 6 0.365 ± 0.048 0.141 ± 0.020 13.8 ± 1.6
2 PCS + BF 10 0.358 ± 0.070 0.158 ± 0.020 NSc 13.9 ± 1.2 NS
3 PCS 10 0.354 ± 0.031 0.154 ± 0.036 14.3 ± 1.8
4 PCS + BF (staged) 5 0.356 ± 0.063 0.159d ± 0.025 0.158 ± 0.009 NS 15.1 ± 2.9 NS
5 IB 5 0.351 ± 0.034 0.328 ± 0.035 <0.01 1.64 ± 0.3 <0.001
6 PCS + IB 10 0.354 ± 0.048 0.138 ± 0.011 NS 13.8 ± 2 NS
7 PCS + IB (staged) 10 0.358 ± 0.054 0.173d ± 0.036 0.162 ± 0.030 NS 16.1 ± 1.6 NS
a

Statistical comparisons were between Group 2 vs. Group 1 (control) and Groups 4 to 7 at sacrifice vs. Group 3 (control).

b

In normal unoperated dogs, the labeling is 1.6 ± 0.4 (7).

c

NS, not significant.

d

The atrophy at 2 weeks was explained by the PCS which was the first stage operation.